NCI budget: a “Yes” to one thing means a “No” to something else, director says.
Also in this 8-page issue: Bush nominates McClellan to head CMS.
FDA to refer false statements by regulated companies to SEC.
Sandra Horning elected ASCO president-elect.
Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.
NIH appoints panel to review conflict of interest rules.
Funding opportunities listed.
PDF file includes 8-page February issue of Business & Regulatory Report.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - In The Headlines: Private funding can’t replace federal funding—but it can help